Knowde Enhanced TDS
Identification & Functionality
- Ingredient Name
- Animal Feed & Nutrition Functions
- Ingredients
- Yeast Extract
- Technologies
Features & Benefits
- Animal Feed & Nutrition Features
Applications & Uses
- Markets
- Especially Recommended For
- Puppies: immature immune systems, parvovirus, first vaccinations, etc.
- Small breeds of dog and cats: bacterial infections, viruses, fungal infections and parasites (leishmania), immunosuppressant medication, etc.
- After a prolonged stay at the vets (physiological stress)
- Dogs and cats with gingivitis and/or other mouth problems
- Older animals with immunosenescence and difficulty swallowing tablets
- Recommended Use
Recommended for use in immunocompromised dogs and cats such as:
Use of IMPROMUNE®
Infectious processes:
• Bacteria (e.g. pyogenic infection), viruses (e.g. calicivirus, papillomatosis), Parasites (e.g.: demodicosis, giardia), fungal infections (e.g.: ringworm, Malassezia)
• Leishmania
Minimum duration 15-20 days
Minimum duration 6 months
Acquired immunosuppression:
• Administration of immunosuppressants (e.g. glucocorticoids)
• Chemotherapy
• Elderly animals, immunosenescence
• Stress:
Postoperative/post-multiple trauma conditions (e.g. Cesarean section, pyometra)
Reproduction (e.g. lactation, large litters) Puppies (e.g.: around vaccine period)
Malnutrition
Before and after treatment, 15-20 days
Before, during and after chemotherapy, 15-20 days
Minimum duration 30 days
Minimum duration 30 days
Minimum duration 30 days
Minimum duration 30 days
- Posology and method of administration
IMPROMUNE® is easy to administer because it is very palatable. The design of the tablets means they can be split to make it easier for smaller animals to ingest.
Depending on the situation, and the animal’s progress, the administration period can be extended at the veterinarian’s discretion.
IMPROMUNE® does not produce any adverse effects.
Weight of animal
Daily tablets
Daily dose
< 10 kg
½
2 ml
11 - 25 kg
1
4 ml
> 26 kg
2
8 ml
Packaging & Availability
- Packaging Type
- Presentation
- In containers of 20 or 40 tablets, pouches of 200 tablets or a 30 ml syringe of palatable paste.
- Each clinical package contains: 20 blister packs of 10 tablets or 12 dispenser sachets.
Storage & Handling
- Storage Conditions
- Store in a cool, dry place.